Signature Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.47M | Sell |
159,332
-308
| -0.2% | -$8.2K | 1.7% | 22 |
|
|
2025
Q4 | $3.98M | Buy |
159,640
+151
| +0.1% | +$3.81K | 1.62% | 27 |
|
|
2025
Q3 | $4.06M | Buy |
159,489
+6,891
| +5% | +$170K | 1.58% | 25 |
|
|
2025
Q2 | $3.7M | Sell |
152,598
-913
| -0.6% | -$21.3K | 1.46% | 29 |
|
|
2025
Q1 | $3.89M | Buy |
153,511
+20,873
| +16% | +$546K | 1.52% | 27 |
|
|
2024
Q4 | $3.52M | Sell |
132,638
-6,329
| -5% | -$172K | 1.41% | 31 |
|
|
2024
Q3 | $4.02M | Buy |
138,967
+2,801
| +2% | +$81.7K | 1.61% | 26 |
|
|
2024
Q2 | $3.81M | Buy |
136,166
+4,898
| +4% | +$135K | 1.67% | 21 |
|
|
2024
Q1 | $3.41M | Buy |
131,268
+6,161
| +5% | +$171K | 1.55% | 30 |
|
|
2023
Q4 | $3.6M | Buy |
+125,107
| New | +$3.78M | 1.66% | 23 |
|
|
2023
Q2 | $3.4M | Buy |
92,581
+9,348
| +11% | +$364K | 1.58% | 31 |
|
|
2023
Q1 | $3.4M | Buy |
83,233
+3,616
| +5% | +$156K | 1.61% | 31 |
|
|
2022
Q4 | $4.08M | Buy |
79,617
+1,162
| +1% | +$55.7K | 2% | 17 |
|
|
2022
Q3 | $3.43M | Sell |
78,455
-113
| -0.1% | -$5.49K | 1.74% | 22 |
|
|
2022
Q2 | $4.12M | Sell |
78,568
-460
| -0.6% | -$23.4K | 2% | 11 |
|
|
2022
Q1 | $4.09M | Buy |
79,028
+5,607
| +8% | +$291K | 1.84% | 15 |
|
|
2021
Q4 | $4.34M | Buy |
73,421
+156
| +0.2% | +$7.73K | 2.19% | 8 |
|
|
2021
Q3 | $3.15M | Sell |
73,265
-19,904
| -21% | -$882K | 1.75% | 30 |
|
|
2021
Q2 | $3.65M | Buy |
93,169
+825
| +0.9% | +$32.1K | 2.03% | 15 |
|
|
2021
Q1 | $3.35M | Buy |
92,344
+6,612
| +8% | +$235K | 1.97% | 16 |
|
|
2020
Q4 | $3.16M | Sell |
85,732
-4,324
| -5% | -$159K | 1.99% | 22 |
|
|
2020
Q3 | $3.14M | Buy |
90,056
+1,867
| +2% | +$65.5K | 2.26% | 16 |
|
|
2020
Q2 | $2.74M | Sell |
88,189
-12
| -0% | -$408 | 2.09% | 21 |
|
|
2020
Q1 | $2.73M | Buy |
88,201
+788
| +0.9% | +$26.9K | 2.4% | 14 |
|
|
2019
Q4 | $3.25M | Buy |
87,413
+806
| +0.9% | +$28.7K | 2.05% | 20 |
|
|
2019
Q3 | $2.95M | Buy |
86,607
+1,761
| +2% | +$64K | 1.95% | 26 |
|
|
2019
Q2 | $3.54M | Buy |
84,846
+101
| +0.1% | +$4.01K | 2.36% | 12 |
|
|
2019
Q1 | $3.42M | Sell |
84,745
-731
| -0.9% | -$29.3K | 2.39% | 11 |
|
|
2018
Q4 | $3.54M | Sell |
85,476
-195
| -0.2% | -$8.1K | 2.75% | 4 |
|
|
2018
Q3 | $3.51M | Sell |
85,671
-793
| -0.9% | -$30.5K | 2.61% | 8 |
|
|
2018
Q2 | $2.98M | Buy |
86,464
+722
| +0.8% | +$24.7K | 2.2% | 18 |
|
|
2018
Q1 | $2.89M | Buy |
85,742
+182
| +0.2% | +$6.26K | 2.23% | 17 |
|
|
2017
Q4 | $2.94M | Buy |
+85,560
| New | +$2.92M | 2.16% | 20 |
|
Other funds holding PFE
Signature Wealth Management Group's PFE Position: Q1 2026 in Review
Signature Wealth Management Group reduced its Pfizer (PFE) stake by 0.19% in Q1 2026, selling an estimated $8.2K and leaving 159,332 shares worth $4.47M. The position accounts for 1.7% of the portfolio, ranked #22.
Signature Wealth Management Group first reported a position in PFE in Q4 2017 and has held it in 33 quarters since. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Signature Wealth Management Group held 159,332 shares of Pfizer worth $4.47M as of Q1 2026.
- Signature Wealth Management Group sold 308 Pfizer shares in Q1 2026, an estimated $8.2K.
- Pfizer made up 1.7% of Signature Wealth Management Group's portfolio in Q1 2026, its #22 holding.
- Signature Wealth Management Group first reported a position in Pfizer in Q4 2017 and has held it in 33 quarters since.
- 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Signature Wealth Management Group's 13F filing for Q1 2026, filed 1 Apr 2026.